Sign up USA
Simcere Pharmaceutical (NYSE:SCR)

Simcere Pharmaceutical (NYSE:SCR)

Share Price
$ 0.00
0 (0.00 %)
Market Cap
$0.00 m
Proactive Investors - Run By Investors For Investors

Simcere Pharmaceutical

Simcere Pharmaceutical are a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer drug Endu in the rapidly growing China market. Our strategic focus is to introduce first-to-market generic and innovative pharmaceutical products for the treatment of diseases.

Market: NYSE:SCR
Sector: Pharmaceuticals

Simcere Pharmaceutical

Interactive graph

col 3
col 4
col 5
col 6
Copyright ©, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use